Yongzhou Hu

USPTO Granted Patents = 9 (Patent Applications = 1)

CIPO Patents = 3

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 5(Granted Patents)

Location History:

Hangzhou, CN (2021 - 2022)
Zhejiang, CN (2018 - 2024)

Company Filing History:

Chinese Academy of Sciences

patents

1 out of 1

Hangzhou Yirui Pharmaceutical Technology Co., Ltd

patent

4. 1 out of 1

Guangzhou Lixin Pharmaceutical Co., Ltd.

patent

5. 1 out of 1

Zhejiang Academy of Traditional Chinese Medicine

patent

6. 1 out of 1

Hangzhou Westan Pharmaceutical Technology Co., Ltd

patent

where one patent can have more than one assignee

Years Active: 2018-2025

where 'Filed Patents' based on already Granted Patents

9 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12404269 - Aminoquinazolinone and aminoisoquinolinone derivatives and application thereof (2025-09-02),

2. 12391660 - Heteroaromatic acetamide derivative, and preparation and use thereof (2025-08-19),

3. 11993576 - N-benzyl-N-arylsulfonamide derivative and preparation and use thereof (2024-05-28),

4. 11591325 - 2-polysubstituted aromatic ring-pyrimidine derivatives, preparation and medical application thereof (2023-02-28),

5. 11319300 - Polyfluoro-substituted aromatic heterocyclic derivative, pharmaceutical composition containing same, and applications thereof (2022-05-03),

6. 11117866 - Terpineol and preparation method and application thereof (2021-09-14),

7. 10822327 - 2-substituted aromatic ring-pyrimidine derivative and preparation and application thereof (2020-11-03),

8. 10233180 - Substituted nitrogen-containing heterocyclic derivatives, pharmaceutical compositions comprising the same and applications of antitumor thereof (2019-03-19),

9. 9856288 - Tripeptide epoxyketone compound constructed by heterocycle and preparation method and use thereof (2018-01-02),

Title: Yongzhou Hu: Innovator in Pharmaceutical Chemistry

Introduction

Yongzhou Hu is a prominent inventor based in Zhejiang, China, known for his significant contributions to pharmaceutical chemistry. With a total of nine patents to his name, he has made remarkable advancements in the field of medicinal compounds.

Latest Patents

Among his latest patents, Yongzhou Hu has developed aminoquinazolinone and aminoisoquinolinone derivatives. These compounds have demonstrated strong inhibitory effects on PI3Kα and PI3Kγ, particularly showing efficacy against PIK3CA mutant tumor cells, such as human breast cancer cell strain MCF7. This innovation holds promise for the development of anti-tumor and anti-inflammatory medications. Another notable patent involves a heteroaromatic acetamide derivative, which has been shown to specifically bind to transient receptor potential ankyrin 1 (TRPA1), potentially offering new treatments for diseases mediated by this receptor.

Career Highlights

Yongzhou Hu has worked with esteemed institutions such as Zhejiang University and the Chinese Academy of Sciences. His research has focused on creating compounds that can be utilized in therapeutic applications, particularly in oncology and inflammatory diseases.

Collaborations

Yongzhou Hu has collaborated with notable colleagues, including Tao Liu and Jia Tao Li, contributing to the advancement of research in his field.

Conclusion

Yongzhou Hu's innovative work in pharmaceutical chemistry has the potential to lead to significant advancements in medical treatments. His contributions through various patents reflect his dedication to improving healthcare through scientific research.

This text is generated by artificial intelligence and may not be accurate.